S

Shandong Boan Biotechnology
6955

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$6.58B
EV
HK$7.10B
Shares Outstanding
574.33M
Beta
0.14

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
HK$9.53
P/E 2025E
40.20x
P/Revenue 2025E
6.46x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Shandong Boan Biotechnology Co., Ltd.

gainify

S

Shandong Boan Biotechnology Co., Ltd.

6955

Shandong Boan Biotechnology Co., Ltd. develops, manufactures, and commercializes biologics in Mainland China and internationally. Its commercialized products include Boyounuo (BA1101) bevacizumab injection for the treatment of metastatic or recurrent non-small cell lu...

Sector

Industry

CEO

Jiang, Hua

Employees

760

IPO Date

Headquarters

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Yantai, Shandong Province China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.